References
- Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54:24–38.
- Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, et al.. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res. 2004;94:e27–e31.
- Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology. 2008;149:2270–82.
- Chen B, Liao WQ, Xu N, Xu H, Wen JY, Yu CA, et al.. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res. 2009;1273:129–37.
- Yatomi K, Miyamoto N, Komine-Kobayashi M, Liu M, Oishi H, Arai H, et al.. Pathophysiological dual action of adiponectin after transient focal ischemia in mouse brain. Brain Res. 2009;1297:169–76.
- Marousi S, Theodorou G, Karakantza M, Papathanasopoulos P, Ellul J. Serum adiponectin acutely after an ischemic stroke: implications for a long-lasting, suppressed anti-inflammatory role. Acta Neurol Scand. 2010;121:277–84.
- Sasaki M, Kawano T, Saito T, Yuzawa M, Saito T, Ikoma A, et al.. Hypoadiponectinemia in patients with cerebral infarction: comparison with other atherosclerotic disorders. Am J Med Sci. 2007;333:140–4.
- Kojima S, Funahashi T, Sakamoto T, Miyamoto S, Soejima H, Hokamaki J, et al.. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003;89:667–8.
- Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al.. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.
- Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al.. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.
- Chen M-P, Tsai JC, Chung FM, Yang SS, Hsing LL, Shin SJ, et al.. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol. 2005;25:821–6.
- Ryan AS, Macko RF, Peters MN, Ivey FM, Prior SJ, Joseph LJ, et al.. Plasma adiponectin levels are associated with insulin sensitivity in stroke survivors. J Stroke Cerebrovasc Dis. 2009;18:214–20.
- Matsumoto M, Ishikawa S, Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke. 2008;39:323–8.
- Stott D, Welsh P, Rumley A, Robertson M, Ford I, Sattar N, et al.. Adipocytokines and risk of stroke in older people: a nested case–control study. Int J Epidemiol. 2009;38:253–61.
- Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al.. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43:1318–23.
- Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;14:561–6.
- Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al.. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85–89.
- Kojima S, Funahashi T, Otsuka F, Maruyoshi H, Yamashita T, Kajiwara I, et al.. Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction. Atherosclerosis. 2007;194:204–13.
- Shibata R, Sato K, Kumada M, Izumiya Y, Sonoda M, Kihara S, et al.. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. Cardiovasc Res. 2007;74:471–9.
- Kim BJ, Lee SH, Ryu WS, Kim CK, Yoon BW. Adipocytokines and ischemic stroke: differential associations between stroke subtypes. J Neurol Sci. 2012;312:117–22.